KPRX·49721T507·US·equity·Healthcare - Biotechnology-13D/G
KPRX (KIORA PHARMACEUTICALS INC) is held by 7 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($95,599), GEODE CAPITAL MANAGEMENT, LLC ($92,349), XTX Topco Ltd ($28,408). Net institutional sentiment: Mixed.
See how KPRX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer